United Kingdom · Biotechnology startup
United Kingdom · Idrx
Idrx is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment.
Funding reportedLast round: Series B
What company datasets say Idrx raised
Funding, as reported
Reported in all242Min the source's currency
Rounds2
Last roundSeries B
Last round dateAug 2024
Investors listed9
Biotechnology in United Kingdom
Startups like it
F2GManchester · founded 1998
COMPASS PathwaysAltrincham · founded 2016
PepgenOxford · founded 2018
Beckley PsytechBeckley · founded 2019
Cambridge EpigenetixChesterford Research Park · founded 2012
Ascend Gene And Cell Therapies Ltd.Altrincham · founded 2021
Green BiologicsAbingdon · founded 2003
Myricx BioLondon · founded 2019
Is this your company?
Add your raise, your deck and your story, and put Idrx in front of investors. Or tell us what we have wrong.